Study to Find Out if Therapy With the Drug Pregabalin Relieves Pain During Shingles Compared With Placebo
Status:
Terminated
Trial end date:
2006-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to see if therapy with the drug pregabalin relieves pain during
shingles compared with placebo. A placebo is an inactive substance. Pregabalin is a drug
marketed as Lyrica™ in the United States for the treatment of seizures, diabetic neuropathy,
and post-herpetic neuralgia. The use of pregabalin and drugs like it for the treatment of
pain during the acute phase of shingles is experimental. Thirty four subjects will complete
the study at the University of California, San Francisco (UCSF) Pain Clinical Research
Center. This study is funded by Pfizer Global Research.